Pathophysiology of preeclampsia and L-arginine/L-citrulline supplementation as a potential strategy to improve birth outcomes

T Ortiz-Cerda, C Mosso, A Alcudia… - Advances in Maternal …, 2023 - Springer
In preeclampsia, the shallow invasion of cytotrophoblast cells to uterine spiral arteries,
leading to a reduction in placental blood flow, is associated with an imbalance of …

Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood

T Chaiworapongsa, R Romero, F Gotsch… - American journal of …, 2023 - Elsevier
Background An antiangiogenic state has emerged as a mechanism of disease in
preeclampsia. Angiogenic biomarkers are used in the risk assessment of this syndrome …

Association between antenatal diagnosis of late fetal growth restriction and educational outcomes in mid-childhood: A UK prospective cohort study with long-term data …

L Olga, U Sovio, H Wong, G Smith, C Aiken - PLoS Medicine, 2023 - journals.plos.org
Background Fetal growth restriction (FGR) is associated with a suboptimal intrauterine
environment, which may adversely impact fetal neurodevelopment. However, analysing …

Objective measures of smoking and caffeine intake and the risk of adverse pregnancy outcomes

RJ Selvaratnam, U Sovio, E Cook… - International Journal …, 2023 - academic.oup.com
Background In pregnancy, women are encouraged to cease smoking and limit caffeine
intake. We employed objective definitions of smoking and caffeine exposure to assess their …

Increased placental sFLT1 (soluble fms-like tyrosine kinase receptor-1) drives the antiangiogenic profile of maternal serum preceding preeclampsia but not fetal …

F Gaccioli, U Sovio, S Gong, E Cook… - …, 2023 - Am Heart Assoc
Background: Preeclampsia and fetal growth restriction (FGR) are both associated with an
increased ratio of sFLT1 (soluble fms-like tyrosine kinase-1) to PlGF (placenta growth factor) …

Histopathologic and transcriptomic profiling identifies novel trophoblast defects in patients with preeclampsia and maternal vascular malperfusion

M Horii, C To, R Morey, MB Jacobs, Y Li, KK Nelson… - Modern Pathology, 2023 - Elsevier
Preeclampsia (PE) is a heterogeneous disease for which the current clinical classification
system is based on the presence or absence of specific clinical features. PE-associated …

[HTML][HTML] Maternal serum levels of soluble fms-like tyrosine kinase-1 and placental growth factor at 20 and 28 weeks of gestational age and the risk of spontaneous …

U Sovio, F Gaccioli, E Cook… - American Journal of …, 2023 - Elsevier
Background Spontaneous preterm birth is the endpoint of multiple different
pathophysiological pathways. Fetal growth restriction, assessed by serial ultrasonic fetal …

Sex differences in placenta-derived markers and later autistic traits in children

A Tsompanidis, L Blanken, ZA Broere-Brown… - Translational …, 2023 - nature.com
Autism is more prevalent in males and males on average score higher on measures of
autistic traits. Placental function is affected significantly by the sex of the fetus. It is unclear if …

Utility of sFtl-1 and Placental Growth Factor Ratio for Adequate Preeclampsia Management

E Ciciu, AM Paṣatu-Cornea, S Dumitru, LC Petcu… - Healthcare, 2023 - mdpi.com
Introduction: The pathophysiology of preeclampsia is represented by placental ischemia and
the release of angiogenic factors. Recent research suggests that using the value of the sFtl …

One-third of patients with eclampsia at term do not have an abnormal angiogenic profile

T Chaiworapongsa, R Romero, F Gotsch… - Journal of Perinatal …, 2023 - degruyter.com
Objectives An abnormal angiogenic profile is present in about one-half of women with
preeclampsia at term. Few studies examined the roles of angiogenic biomarkers in …